Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostacyclin: effects on cyclic AMP in bone cells.

J C Robin, M J Brown, N Weinfeld

    Research Communications in Chemical Pathology and Pharmacology
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Hemophilia D factor (factor XII), red-cell deformability and platelet aggregates in raptors.

    Journal of medicine·2007
    Same author

    Grand Rounds at the British Hypertension Society: renal artery stenosis.

    Journal of human hypertension·2007
    Same author

    Confirmation of a role for the 389R>G beta-1 adrenoceptor polymorphism on exercise capacity in heart failure.

    Heart (British Cardiac Society)·2005
    Same author

    Use of an enzyme-linked immunosorbent assay to diagnose avian tuberculosis in a captive collection of wildfowl.

    Avian pathology : journal of the W.V.P.A·2005
    Same author

    Differential expression of adenylyl cyclase subtypes in human cardiovascular system.

    Molecular and cellular endocrinology·2004
    Same author

    N-acetylcysteine enhances muscle cysteine and glutathione availability and attenuates fatigue during prolonged exercise in endurance-trained individuals.

    Journal of applied physiology (Bethesda, Md. : 1985)·2004

    Prostacyclin (PGI2) differentially affects bone cells. Osteoclasts are more sensitive to PGI2 than osteoblasts, suggesting a role in bone remodeling regulation.

    Area of Science:

    • Bone biology
    • Cell signaling
    • Endocrinology

    Background:

    • Prostacyclin (PGI2) is a lipid mediator with known roles in vascular and inflammatory processes.
    • Bone remodeling involves the coordinated action of osteoblasts and osteoclasts.
    • The specific effects of PGI2 on distinct bone cell populations are not fully elucidated.

    Purpose of the Study:

    • To investigate the differential effects of Prostacyclin (PGI2) on osteoclasts and osteoblasts.
    • To determine the dose-dependent response of rat bone cell populations to PGI2.
    • To explore the potential role of PGI2 in regulating bone cell activity.

    Main Methods:

    • Isolation of specific rat bone cell populations (osteoclasts and osteoblasts) using sequential collagenase digestion of calvariae.

    Related Experiment Videos

  • Measurement of cyclic AMP (cAMP) levels in response to varying doses of PGI2.
  • Characterization of cell populations by acid phosphatase and alkaline phosphatase levels, and bone resorption assays.

    • Main Results:

    • Prostacyclin (PGI2) significantly increased cyclic AMP (cAMP) in isolated rat bone cells.
    • Osteoclastic bone cell populations exhibited higher sensitivity to PGI2, showing responses at lower doses and greater increases in cAMP at higher doses compared to osteoblastic populations.
    • Osteoblastic populations showed a diminished and delayed cAMP response to PGI2, requiring higher concentrations for significant effects.

    Conclusions:

    • Prostacyclin (PGI2) exerts differential effects on osteoclasts and osteoblasts.
    • The observed differential sensitivity suggests PGI2 may play a regulatory role in the balance of bone resorption and formation.
    • These findings contribute to understanding the mechanism of action for endogenously produced PGI2 in bone metabolism.